Trial Profile
The effectiveness and safety of neoadjuvant chemotherapy of lobaplatin combined with 5-FU, concurrent chemotherapy of lobaplatin and IMRT in local-regionally advanced nasopharyngeal carcinoma : a prospective, non-controlled clinical trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Lobaplatin (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date 30 Jun 2013 added as reported by Chinese Clinical Trial Register record.
- 12 Apr 2012 New trial record